Straumann Holding AG

STMN

Company Profile

  • Business description

    Straumann is a global leader in dental implants and orthodontics solutions. Its portolio includes abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it controls over one-third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: [email protected]

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    12,000

Stocks News & Analysis

stocks

5 star fully franked ASX dividend payer

Investors in cheap ASX share with a narrow moat enjoys a high yield, but there are risks investors should be aware of.
stocks

An undervalued stock to buy that even Warren Buffett likes

Trading at an 18% discount, this wide-moat stock is a rare find.
stocks

ASX REIT downgraded following underwhelming exit

Discounted exit raises investor concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,886.6035.900.41%
CAC 408,078.480.680.01%
DAX 4025,374.4234.22-0.13%
Dow JONES (US)51,481.51347.11-0.67%
FTSE 10010,684.8810.37-0.10%
HKSE24,560.1482.37-0.33%
NASDAQ26,820.38248.34-0.92%
Nikkei 22565,209.37668.25-1.01%
NZX 50 Index13,683.63147.05-1.06%
S&P 5007,683.6959.72-0.77%
S&P/ASX 2008,709.3029.600.34%
SSE Composite Index3,839.8016.180.42%

Market Movers